Your browser doesn't support javascript.
COVID-19 vaccine prioritisation for people with cystic fibrosis.
Carr, Siobhán B; Cosgriff, Rebecca; Harutyunyan, Satenik; Middleton, Peter G; Ruseckaite, Rasa; Ahern, Susannah; Daneau, Géraldine; Filho, Luiz Vicente R F da Silva; Stephenson, Anne L; Cheng, Stephanie Y; Melo, Joel; Corvol, Harriet; Burgel, Pierre-Régis; Nährlich, Lutz; McKone, Edward; Colombo, Carla; Salvatore, Marco; Padoan, Rita; Abdrakhmanov, Olzhas; Gulmans, Vincent; Byrnes, Catherine A; Amelina, Elena; Kondratyeva, Elena; Zhekayte, Elena; Kashirskaya, Nataliya; Zampoli, Marco; Pastor-Vivero, M Dolores; Mondejar-Lopez, Pedro; de Monestrol, Isabelle; Jung, Andeas; McClenaghan, Elliot; Brownlee, Keith; Rizvi, Samar; Goss, Christopher H; Elbert, Alexander; Faro, Albert; Gutierrez, Hector; Marshall, Bruce C.
  • Carr SB; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Cosgriff R; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom. Electronic address: rebecca.cosgriff@cysticfibrosis.org.uk.
  • Harutyunyan S; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Middleton PG; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Ruseckaite R; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Ahern S; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Daneau G; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Filho LVRFDS; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Stephenson AL; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Cheng SY; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Melo J; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Corvol H; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Burgel PR; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Nährlich L; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • McKone E; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Colombo C; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Salvatore M; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Padoan R; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Abdrakhmanov O; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Gulmans V; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Byrnes CA; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Amelina E; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Kondratyeva E; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Zhekayte E; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Kashirskaya N; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Zampoli M; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Pastor-Vivero MD; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Mondejar-Lopez P; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • de Monestrol I; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Jung A; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • McClenaghan E; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Brownlee K; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Rizvi S; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Goss CH; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Elbert A; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Faro A; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Gutierrez H; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
  • Marshall BC; Cystic Fibrosis Trust, Data & Quality Improvement, 1 Aldgate, London EC3N1RE, United Kingdom.
J Cyst Fibros ; 20(4): 715-716, 2021 07.
Article in English | MEDLINE | ID: covidwho-1185046
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Patient Selection / Cystic Fibrosis / COVID-19 Vaccines / COVID-19 / Health Policy / Health Priorities Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: J Cyst Fibros Year: 2021 Document Type: Article Affiliation country: J.jcf.2021.03.028

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Patient Selection / Cystic Fibrosis / COVID-19 Vaccines / COVID-19 / Health Policy / Health Priorities Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: J Cyst Fibros Year: 2021 Document Type: Article Affiliation country: J.jcf.2021.03.028